Lexicon Pharmaceuticals(LXRX) - 2023 Q4 - Annual Results

Exhibit 10.1 PREFERRED STOCK PURCHASE AGREEMENT dated as of March 11, 2024 by and among LEXICON PHARMACEUTICALS, INC. and THE PURCHASERS PARTY HERETO RECITALS WHEREAS, each Purchaser, severally and not jointly, proposes to buy from the Company, and the Company proposes to issue and sell to the Purchasers, certain shares of its Series A Convertible Preferred Stock, par value $0.01 per share (the "Preferred Stock"), in reliance on the exemption from registration afforded by the provisions of Section 4(a)(2) o ...